Stay updated on Reslizumab in EGPA: Clinical Trial

Sign up to get notified when there's something new on the Reslizumab in EGPA: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Reslizumab in EGPA: Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    No significant changes observed between the old and new Study Details pages. Core study information and navigation remain the same.
    Difference
    0.5%
    Check dated 2025-10-28T02:47:00.000Z thumbnail image
  3. Check
    36 days ago
    Change Detected
    Summary
    - Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.
    Difference
    4%
    Check dated 2025-10-06T15:52:00.000Z thumbnail image
  4. Check
    43 days ago
    Change Detected
    Summary
    - Version updated from v3.0.2 to v3.1.0. - New contact details added: multiple phone numbers and an email.
    Difference
    0.1%
    Check dated 2025-09-29T09:50:00.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Bump from v3.0.1 to v3.0.2 and removal of 'Back to Top'; no substantive changes to core content.
    Difference
    0.2%
    Check dated 2025-09-15T00:01:08.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content, names, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-09-07T20:41:50.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The web page has added a facility name and location, along with several medical conditions related to respiratory diseases, while removing a significant amount of information about various diseases and conditions, including some previously listed medications.
    Difference
    4%
    Check dated 2025-08-31T12:58:38.000Z thumbnail image

Stay in the know with updates to Reslizumab in EGPA: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Reslizumab in EGPA: Clinical Trial page.